Thomas Habeler
About Thomas Habeler
Thomas Habeler is a Key Account Manager at BeiGene in Wien, Österreich, with over 20 years of experience in the pharmaceutical and biotechnology industry, specializing in hematology and oncology sales management.
Company
Thomas Habeler is currently employed at BeiGene as a Key Account Manager in Wien, Österreich. BeiGene is a global biotechnology company that focuses on discovering and developing innovative molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.
Title
Thomas Habeler holds the title of Key Account Manager at BeiGene. In addition to his role at BeiGene, he also works as a Trainer in Molecular Oncology at Trainer Molekulare Onkologie in Wien.
Education and Expertise
Thomas Habeler studied at Universität Wien, where he specialized in molecular genetics and earned a doctorate (Dr.) in the field. His academic and professional focus has been on the pharmaceutical and biotechnology sectors, with a specialization in hematology and oncology sales management. He has over 20 years of experience in these fields.
Professional Background
Thomas Habeler has a robust work history in the pharmaceutical and biotechnology industry. He previously worked at Bristol-Myers Squibb as National Sales Manager Hematology from 2019 to 2022. From 2018 to 2022, he served as National Sales Manager Hem/Onc at Celgene, where he also held the role of Key Account Manager from 2006 to 2018. Additionally, Thomas worked at Novartis as a PM from 2004 to 2006, and at Amgen in various roles including Clinical Research Associate (CRA), Clinical Project Specialist (CPS), and Project Manager (PM) from 1999 to 2004.
Career Achievements
With a substantial career in the pharmaceutical industry, Thomas Habeler has consistently demonstrated expertise in key account management and national sales leadership. He has successfully managed national sales teams and has extensive experience in clinical research and project management. His roles have spanned across leading companies like Amgen, Novartis, Celgene, and Bristol-Myers Squibb, showcasing a strong background in both client relations and sales strategy.